Table 3:
Markers of myocardial damage
| Marker | Group | Before RIPC | 6 h after CPB | 24 h after CPB | 48 h after CPB |
|---|---|---|---|---|---|
| cTnI (ng/ml) | RIPC | 0.01 (0.01; 0.01) | 2.13 (1.27; 3.15)^ | 0.93 (0.45; 2.21)^ | 0.76 (0.2; 1.09)^ |
| Control | 0.01 (0.01; 0.01) | 2.37 (1.48; 5.36)^ | 0.87 (0.58; 2.46)^ | 0.54 (0.39; 2)^ | |
| CK-MB (U/l) | RIPC | 20 (14; 22) | 45.5 (32; 53.5)^ | 48.5 (32; 66)^ | 49.5 (42; 70)^ |
| Control | 18 (14; 23) | 39 (33; 58)^ | 45 (33; 58)^ | 47.5 (38.5; 69.5)^ |
Difference confidence level: *P < 0.05 when RIPC patients are compared with the control group, ^P < 0.05 when compared with values before CPB.